Gw Pharmaceuticals Plc (0IT7) 시세

vance couldn't keep his eyes off of the couch.

I asked AI about NEOM and Ramadan...

Ramadan can have a significant impact on productivity in the Middle East, including NEOM (The Line) in Saudi Arabia. While it's a sacred time for Muslims, fasting and changed working hours can affect work pace and efficiency.

Typical

Your trump/hatred has blinded you -- get a grip -- the free world needs the EU to become a major military power -- the USA has nearly bankrupted itself providing existing security -- we shall see if the EU measures up -- otherwise ww3 a real possibility

Bashing 😂😂😂

Allergic to truth?

Zakaria: Dem Cities ‘Are Terribly Run’, I Live in NY, ‘You Get Nothing For’ High Taxes

Ian Hanchett1 Mar 2025

During the online “Overtime” segment of Friday’s broadcast of HBO’s “Real Time,” Washington Post columnist and CNN host Fareed Zakaria said that “If you look at

I'm thinking major news. Got my shares set at $10,00 now. I may move higher after this week. Not sure why this isn't at $20 to $25 per share right now.

I believe a large percentage of muskrat's billions in wealth is on paper. By the speculated stock price of his assorted scams.
So saying tesla is 292. @ 3.5 BILLION outstanding shares, and the marketers claim his car company is worth 1.5 trillion.
Is it really? No. That's the false ma

VMIR

The VMIR is Down -4.18%, after this week’s performance. So without further ado the info is below. Remember This Index Is showed in dollar terms.

The 97 Original Stocks ($1,000.00)
[pre]
Symbol Value Of Investment
AATC $1,128.75
ACCO $

Where in the world are you that its Sunday already?

VMIR

The VMIR is Down -4.18%, after this week’s performance. So without further ado the info is below. Remember This Index Is showed in dollar terms.

The 97 Original Stocks ($1,000.00)
[pre]
Symbol Value Of Investment
AATC $1,128.75
ACCO $

This is a composition of leftist propaganda articles. Show me anything from the actual project 2025 website and then we can have a real conversation.

Otherwise this is just a wraparound smear.

Try due diligence, it's better than pissing away your money.

"The company has achieved the hardest part-developing an extremely complex technology and proving it, allowing it to be ready for material commercial success in global crude transport markets."

When or where has ANYTHING that Qsep has claimed been proven? It hasn't and you or any ot

they(NAKED SHORTING) IS AS REAL AS SCAMBOARDS!!! IN OTHER WORDS, they DON'T EXIST!!!

A little humor-

https://media.gettr.com/group7/getter/2025/03/01/10/83ed6188-18bc-e73f-083c-b7fdb4abf687/f8cdcd69334297a5a5ea7c84394b508d_768x0.jpeg

VMI/VMIR Differential Chart
[pre]
VMI VMIR Differential
1/3/2025 0.15% 0.15% 0.00%
1/10/2025 -2.43% -2.43% 0.00%
1/17/2025 1.06% 1.06% 0.00%
1/24/2025 2.45% 2.45% 0.00%
1/31/2025 0.85% 0.85% 0.00%
2/7/2025 -0.08% -0

VMI/VMIR Differential Chart
[pre]
VMI VMIR Differential
1/3/2025 0.15% 0.15% 0.00%
1/10/2025 -2.43% -2.43% 0.00%
1/17/2025 1.06% 1.06% 0.00%
1/24/2025 2.45% 2.45% 0.00%
1/31/2025 0.85% 0.85% 0.00%
2/7/2025 -0.08% -0

VMI (Sorted by % Return)
[pre]
Symbol % Up/Down
CXB.TO 31.80%
BURCA 25.90%
HLF 24.07%
AHCO 19.54%
IBEX 17.78%
SVC 17.32%
AVNW 15.57%
AATC 12.88%
CTUY 12.63%
MD 12.58%
PSIX 12.17%
INMD 12.10

VMI (Sorted by % Return)
[pre]
Symbol % Up/Down
CXB.TO 31.80%
BURCA 25.90%
HLF 24.07%
AHCO 19.54%
IBEX 17.78%
SVC 17.32%
AVNW 15.57%
AATC 12.88%
CTUY 12.63%
MD 12.58%
PSIX 12.17%
INMD 12.10

I dont know what those forecasts are based on, possibly this time they dont have all the right parameters?

It didn’t

VMI (As of 2/28/25)

The VMI is Down -4.36%, after this week’s performance. So without further ado the info is below.
[pre]
Symbol % Up/Down
AATC 12.88%
ACCO -11.05%
AHCO 19.54%
AMPH -23.43%
AMRX 9.47%
ARMN 5.71%
ASI

VMI (As of 2/28/25)

The VMI is Down -4.36%, after this week’s performance. So without further ado the info is below.
[pre]
Symbol % Up/Down
AATC 12.88%
ACCO -11.05%
AHCO 19.54%
AMPH -23.43%
AMRX 9.47%
ARMN 5.71%
ASI

while the WGT lot finds and adjusts apologist explanations to suit.

Meanwhile the naysayers talk BIG trash right up until November when EMA approves Blarcamesine, even after EMA acceptance and JPAD publication point to a top quartile percentage likelihood of EMA A-273 approval. The na